Results 131 to 140 of about 21,488 (194)

Recurrent subacute stent thrombosis after drug-eluting stent implantation: a case report. [PDF]

BMC Cardiovasc Disord
Yang Y, Jiang J, Chen Z, Fan C.
europepmc   +1 more source

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era. [PDF]

Curr Cardiol Rep
Spadafora L, Quarta R, Martino G, Romano L, Greco F, Curcio A, Gori T, Spaccarotella C, Indolfi C, Polimeni A.   +9 more
europepmc   +1 more source

Comparison of the efficacy of intravascular lithotripsy and rotational atherectomy as adjunctive therapy before drug-eluting stent implantation in calcified coronary lesions (CCS- Coronary Calcification Study). [PDF]

BMC Cardiovasc Disord
Pleva L, Kukla P, Konde A.
europepmc   +1 more source

Drug-coated balloon vs drug-eluting stent in de novo coronary lesions: a propensity score matched cohort study. [PDF]

Clin Res Cardiol
Baumer U, Steinacher E, Hammer A, Kazem N, Hofer F, Frey B, Lang I, Hengstenberg C, Hemetsberger R, Sulzgruber P, Niessner A, Koller L.   +11 more
europepmc   +1 more source

Drug-coated balloon angioplasty or drug-eluting stent implantation? a focus after the REC-CAGEFREE1 trial. [PDF]

Eur Heart J Suppl
Leone PP, Colombo A.
europepmc   +1 more source

Study on the potential clinical significance of subclinical stent edge effects after drug-eluting stent implantation. [PDF]

Sci Rep
Xu Y, Wang YF, Zhao MY, You W, Xu T, Meng PN, Wu XQ, Wu ZM, Kong XH, Yin DL, Zhan ME, Jia HB, Liu B, Ye F.   +13 more
europepmc   +1 more source

Efficacy of Drug-Coated Balloon versus Drug-Eluting Stent for Patients with De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis. [PDF]

Med Princ Pract
Haq AU, Suhail A, Ahsan W, Maqbool H, Nawal A, Hassan H, Bungish MK, Shahid MA, Wazir HU, Yousaf H, Rehman MEU, Ahmad Cheema H, Alsubari AAAMA, Khan MA, Nadeem B, Ahmed R, Ahmad A.   +16 more
europepmc   +1 more source

Impact of alirocumab on neoatherosclerosis formation and vessel healing after drug-eluting stent implantation in patients with acute myocardial infarction: a substudy of the PACMAN-AMI trial. [PDF]

Int J Cardiovasc Imaging
Kakizaki R, Ueki Y, Koskinas KC, Shibutani H, Losdat S, Biccirè FG, Otsuka T, Häner JD, Lønborg J, Kaiser C, Iglesias JF, Ondracek AS, Spirk D, Siontis GCM, Daemen J, Engstrøm T, Lang IM, Räber L.   +17 more
europepmc   +1 more source

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis. [PDF]

Rev Cardiovasc Med
Liu B, Li M, Liu J, Xie L, Li J, Liu Y, Niu C, Xiao D, Li J, Zhang L.   +9 more
europepmc   +1 more source

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions. [PDF]

JACC Asia
Horie K, Takahara M, Iida O, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Tada N.   +8 more
europepmc   +1 more source